Evaluation and Determination of a Suitable Passage Number of Codon Pair Deoptimized PRRSV-1 Vaccine Candidate in Pigs

Viruses. 2023 Apr 27;15(5):1071. doi: 10.3390/v15051071.

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) is major economic problem given its effects on swine health and productivity. Therefore, we evaluated the genetic stability of a codon pair de-optimized (CPD) PRRSV, E38-ORF7 CPD, as well as the master seed passage threshold that elicited an effective immune response in pigs against heterologous virus challenge. The genetic stability and immune response of every 10th passage (out of 40) of E38-ORF7 CPD was analyzed through whole genome sequencing and inoculation in 3-week-old pigs. E38-ORF7 CPD passages were limited to 20 based on the full-length mutation analysis and animal test results. After 20 passages, the virus could not induce antibodies to provide effective immunity and mutations accumulated in the gene, which differed from the CPD gene, presenting a reason for low infectivity. Conclusively, the optimal passage number of E38-ORF7 CPD is 20. As a vaccine, this may help overcome the highly diverse PRRSV infection with substantially enhanced genetic stability.

Keywords: ORF7; PRRSV-1; codon pair deoptimization; genetic stability; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral
  • Codon
  • Mutation
  • Porcine Reproductive and Respiratory Syndrome* / genetics
  • Porcine Reproductive and Respiratory Syndrome* / prevention & control
  • Porcine respiratory and reproductive syndrome virus* / genetics
  • Swine
  • Viral Vaccines* / genetics

Substances

  • Codon
  • Viral Vaccines
  • Antibodies, Viral

Grants and funding

The present work was financially supported by Animal and Plant Quarantine Agency grant number M-1543083-2020-23-01.